Chemical activators of Olr1331 can influence the protein's activity through various biochemical mechanisms that involve direct phosphorylation or changes in cellular signaling cascades that lead to the protein's activation. Forskolin can activate adenylate cyclase, which increases the levels of cyclic AMP (cAMP) within the cell. This rise in cAMP can then activate protein kinase A (PKA), a kinase that can phosphorylate a broad array of targets, which includes the potential to phosphorylate and activate Olr1331. Similarly, Isoproterenol acts on beta-adrenergic receptors that also lead to an elevation of cAMP and subsequent PKA activation, which can then phosphorylate and activate Olr1331. Phorbol 12-myristate 13-acetate (PMA) directly activates protein kinase C (PKC), which could target Olr1331 for phosphorylation and activation if it is within PKC's substrate profile.
Further, Ionomycin, by increasing the intracellular concentration of calcium, can activate calcium-dependent kinases which then have the potential to phosphorylate and activate Olr1331. Thapsigargin, through the inhibition of the SERCA pump, raises cytosolic calcium levels, which could also trigger kinases to phosphorylate and activate Olr1331. BAY K8644 stimulates L-type calcium channels, leading to an increased calcium influx that can activate calcium-dependent signaling and potentially Olr1331. Zinc sulfate, as a cofactor, can enhance the activity of enzymes that may be responsible for Olr1331 activation. Anandamide activates cannabinoid receptors that are coupled to intracellular signaling pathways, possibly leading to the activation of kinases that phosphorylate Olr1331. Dibutyryl cAMP, a cAMP analog, directly activates PKA, which could also target Olr1331 for phosphorylation. IBMX works by inhibiting phosphodiesterases, thus increasing cAMP levels and activating PKA, which may phosphorylate Olr1331. FPL 64176 activates calcium channels, thereby potentially activating kinases that phosphorylate and activate Olr1331. Lastly, A23187 (Calcimycin) is a calcium ionophore that raises intracellular calcium levels, which can activate kinases that phosphorylate and lead to Olr1331 activation. Each of these chemicals, through their diverse actions on cellular signaling pathways, can lead to the activation of Olr1331 by fostering an environment that promotes its phosphorylation and consequent activation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Acts on beta-adrenergic receptors to increase intracellular cAMP, activating PKA. PKA phosphorylates various proteins, and if Olr1331 is a substrate, this would result in its activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC, which can phosphorylate a range of proteins, potentially including Olr1331, leading to its functional activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium concentration, which can activate calcium-dependent kinases that may phosphorylate and activate Olr1331. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits the SERCA pump, raising cytosolic calcium levels, which could activate kinases that phosphorylate and activate Olr1331. | ||||||
(±)-Bay K 8644 | 71145-03-4 | sc-203324 sc-203324A sc-203324B | 1 mg 5 mg 50 mg | $84.00 $196.00 $817.00 | ||
Stimulates L-type calcium channels, increasing calcium influx. The elevated calcium can activate kinases which may then phosphorylate and activate Olr1331. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Serves as a cofactor for many enzymes, potentially including ones that could phosphorylate and activate Olr1331. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
A stable cAMP analog that directly activates PKA, which may phosphorylate and activate Olr1331. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Inhibits phosphodiesterases, leading to increased cAMP levels and activation of PKA, which could then phosphorylate and activate Olr1331. | ||||||
FPL-64176 | 120934-96-5 | sc-201491 | 5 mg | $83.00 | 1 | |
Activates calcium channels, leading to an increase in intracellular calcium, which activates kinases that could phosphorylate and activate Olr1331. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A calcium ionophore that raises intracellular calcium levels, potentially activating kinases that would phosphorylate and lead to the activation of Olr1331. | ||||||